Marcio Souza - 13 May 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Executive Officer, Director
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
13 May 2022
Net transactions value
+$12,247
Form type
4
Filing time
18 May 2022, 17:39:42 UTC
Previous filing
11 Jan 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $12,247 +1,392 +0.87% $8.80* 162,184 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).